Contact Us:

670 Lafayette Ave, Brooklyn,
NY 11216

+1 800 966 4564
+1 800 9667 4558

Dear Well-wishers,

Even as I start this January 2022 edition of Oviya MedSafe’s newsletter (the 112th in the series since April 2012), I am so excited to share with you that Oviya MedSafe is to turn ten soon! The journey of brand Oviya MedSafe which began humbly on 14th March 2012 has evolved to that of a highly successful global expedition over the past decade, thanks to all of your support. We as a team are all set to celebrate our 10th anniversary in a meaningful manner with your heartfelt wishes and seek your encouraging participation as well, for the purpose 😉

While wondering how I could briefly emphasize on the essence of what Oviya MedSafe stands for, a forwarded WhatsApp message about the Chinese Bamboo Tree caught my attention with its striking relevance to our organization’s history. Essentially, what it highlighted was that Chinese Bamboo Trees never appeared to grow during their first 5 years of life despite the best botanical care but quickly went on to attain a height of 90 feet during the subsequent 6 weeks. Although a naive spectator could assert that the trees grew rapidly to be 90 feet tall within 6 weeks, the truth was that the trees were never idle and, as the Indian cricket legend Mr Rahul Dravid puts it, were rather strengthening their roots for the first 5 years in order to be prepared for the phenomenal growth that was to follow. Effectively, the 90 feet height was a result of all the cumulative efforts put in throughout the 5 years and 6 weeks period.

Oviya MedSafe’s metamorphosis from a then bootstrapped start-up Pharmacovigilance consultancy firm to a now renowned self-sufficient organically developed well-structured multinational organization in the discipline has been no different from the Chinese Bamboo Trees including the timelines, considering the monumental achievements we have to our credit in the past five years. At this juncture, I express my sincere gratitude to everyone who has been part of our journey and contributed to our growth so far. Given our robust pipeline, I am quite sure much bigger accolades are waiting for us in the future.

In spite of Oviya MedSafe having a strong reason in hand to organize a fun-filled
entertaining event to celebrate this milestone, I am proud to announce that we have decided to continue treading our chosen path of spreading knowledge about Pharmacovigilance instead. Part of this thought stems from the fact that we have often enjoyed the pleasure of giving back to the society and doing so as often as possible only makes us much better professionals in our fields. Further, understanding the fact that the Pharmacovigilance world is literally spread across the globe and hosting the event virtually would be the most appropriate way to cut across the barriers pertaining to location and logistics. And, here is what we have planned for the celebration:

Topic: “Pharmacovigilance: Of The Pill; For The People”
Presented by: Dr J Vijay Venkatraman & Team
Format: Virtual Colloquium on Zoom Platform
Date: Friday, 11th March 2022
Time: 4 to 5:30 PM IST (GMT+5:30)
Registration: Free of cost but mandatory (First Come First Serve)

Link to register: https://zoom.us/meeting/register/tJErdu6trjwjGNOUCErYaQ6vTdZzqrvN3EK

I look forward to your participation in this colloquium which we as Oviya MedSafe team believe would have pertinent take-home points for every attendee regardless of their level of Pharmacovigilance expertise. Please feel free to share this information with anyone who may be interested.

Eager to connect with you through our February 2022 newsletter soon,

With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA, FPIPA (UK)

Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Coimbatore, India
Phone: +91 422 2444442

Director,
Oviya MedSafe UK Ltd,
London, UK
Phone: +44 20 3393 6037 

Web: www.oviyamedsafe.com
Mail: info@oviyamedsafe.com
Follow us on FacebookLinkedInTwitter & YouTube

Leave a comment

Your email address will not be published. Required fields are marked *